Dose FractionationRadiotherapy DosageTreatment OutcomeTime FactorsIron-Dextran ComplexDrug Administration ScheduleDose-Response Relationship, RadiationCholesterolLipidsProspective StudiesRadiation DosageHealth Care CostsDouble-Blind MethodFollow-Up StudiesRadiotherapy, ConformalCombined Modality TherapyCholesterol, LDLCholesterol, HDLRetrospective StudiesDietInsurance Claim ReviewDose-Response Relationship, DrugRadiation InjuriesTriglyceridesBody WeightRisk FactorsAbsorptiometry, PhotonUnited StatesDietary FatsInfusions, IntravenousSex Hormone-Binding GlobulinRadiometryRadiotherapyAdministration, OralPregnancyEnergy IntakeCohort StudiesBody CompositionRadiotherapy Planning, Computer-AssistedBody Mass IndexAntineoplastic Combined Chemotherapy ProtocolsLipoproteinsBone DensityDrug EvaluationRadiotherapy, High-EnergyCross-Over StudiesRegression AnalysisCost-Benefit AnalysisSex FactorsCross-Sectional StudiesAge FactorsInjections, IntravenousCisplatinRadiotherapy, Intensity-ModulatedOrgan SizeTestosteroneFollicle Stimulating Hormone, HumanRandom AllocationLiverRelative Biological EffectivenessBlood PressureRadiosurgeryBrachytherapyRadiotherapy, AdjuvantCase-Control StudiesNimustineLethal Dose 50Lung NeoplasmsSolar ActivityFat NecrosisArea Under CurveHalf-LifeLinear ModelsRadiotherapy, Computer-AssistedMultivariate AnalysisObesityAntineoplastic AgentsReference ValuesEuropean Continental Ancestry GroupDoxorubicinCyclophosphamideCardiovascular DiseasesAgingInsulinBlood GlucoseEnergy MetabolismSurvival AnalysisDisease-Free SurvivalQuestionnairesFluorouracilDiabetes Mellitus, Type 2Metabolic Clearance RateSurvival RateInjections, IntramuscularNeoplasm StagingExerciseCarboplatinHypertensionRadiation PneumonitisInfusions, Parenteral